Ilya Yu. Titov

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation

Afsar Mian, Alireza Rafiei, Isabella Haberbosch et al. · Leukemia · 2014 · 65 citations

Medicine, Medicinal Chemistry, Oncology +6

Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin

Marina Sagnou, Fedor N. Novikov, Ekaterina S. Ivanova et al. · European Journal of Medicinal Chemistry · 2020 · 50 citations

Medicine, Oncology, Pharmacology +11

Quantifying Possible Routes for SpnF-Catalyzed Formal Diels–Alder Cycloaddition

Michael G. Medvedev, Alexey A. Zeifman, Fedor N. Novikov et al. · Journal of the American Chemical Society · 2017 · 44 citations

Natural Sciences, Biochemistry, Chemistry +15

Inhibition of SYK and cSrc kinases can protect bone and cartilage in preclinical models of osteoarthritis and rheumatoid arthritis

Fedor N. Novikov, Maria V. Panova, Ilya Yu. Titov et al. · Scientific Reports · 2021 · 18 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Rational design and synthesis of new PARP1 inhibitors

Leonid V. Romashov, Alexey A. Zeifman, Alexandra L. Zakharenko et al. · Mendeleev Communications · 2012 · 12 citations

Pharmacy, Medicinal Chemistry, Oncology +14